Newsdesk

7 hours ago

Trane Technologies Plc (TT) Oppenheimer Industrial Growth Conference

Trane Technologies Plc (NYSE: TT) FY 2026 Corporate Conference

Merck & Co., Inc. (MRK) FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer »

« United Therapeutics Corporation (UTHR) Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026

Newsdesk: